First Aid Clinical Pattern Recognition for the USMLE Step 1 Notes

Page 15: Introduction to Clinical Pattern Recognition

USMLE Step 1 has transitioned to integrated clinical case-based questions. Success requires the ability to recognize clinical patterns, develop a differential diagnosis, and apply basic science concepts to "classic" vignettes.

Anatomy of a USMLE Step 1 Question
  • Power Statement: The introductory sentence containing the patient's age, gender, significant past medical history (PMH), and the chief concern.
  • Additional History: Clues regarding cardiovascular risk factors (smoking, hypertension, diabetes), immunization status, travel history, or dietary exposures.
  • Physical Exam (PE): Brief descriptions of key findings or specific maneuvers (e.g., Fundoscopy in a child with Tay-Sachs disease exhibiting retinal reddening).
  • Laboratory Findings: Results that must be interpreted against provided reference ranges. Long lists of values often require identifying the most relevant results (e.g., metabolic or endocrine cases).
  • Imaging: Radiological or pathological specimens. Finding the principal finding in the image can often bypass the need for reading the entire text.

Page 19-27: Chapter 1: Biochemistry

Failure to Thrive (FTD) Patterns
  • Pyruvate Dehydrogenase Complex (PDC) Deficiency: An X-linked defect causing a transition failure from glycolysis to the TCA cycle. Pyruvate builds up and is converted to lactate (acidosis) and alanine. Treatment involves a ketogenic diet (high fat, low carbohydrate).
  • Hereditary Fructose Intolerance: Deficiency in aldolase B. Fructose-1-phosphate accumulates and traps phosphate inside cells, inhibiting glycogenolysis and gluconeogenesis, causing hypoglycemia.
  • Von Gierke Disease (GSD Type I): Deficiency in glucose-6-phosphatase. Findings include severe fasting hypoglycemia, hepatomegaly (due to glycogen/fat storage), and hyperuricemia.
  • Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency: Defect in β\beta-oxidation. Presents as hypoketotic hypoglycemia during fasting or illness.
  • Ornithine Transcarbamylase (OTC) Deficiency: The most common urea cycle disorder. X-linked recessive. Results in hyperammonemia and increased orotic acid in urine.
Developmental Delay and Genomic Imprinting
  • Tay-Sachs Disease: Autosomal recessive lysosomal storage disorder (hexosaminidase A deficiency). Characteristic "cherry-red spot" in the macula and an "onion skin" lysosome morphology; lacks hepatosplenomegaly.
  • Hurler Syndrome: Deficiency of α\alpha-L-iduronidase. Presents with coarse facial features, corneal clouding, and developmental regression.
  • Prader-Willi Syndrome: Genomic imprinting disorder involving deletion of paternal chromosome 15q11-13. Characterized by neonatal hypotonia followed by insatiable appetite and obesity.

Page 28-38: Chapter 2: Immunology

Primary Immunodeficiencies
  • X-linked (Bruton) Agammaglobulinemia: BTK gene defect prevents B-cell maturation. Absent B-cells and germinal centers. Recurrent pyogenic infections start after 6 months of age.
  • DiGeorge Syndrome (Thymic Aplasia): 22q11 deletion. Failure of 3rd and 4th pharyngeal pouches. Triad: Hypocalcemia (tetany), congenital heart defects (Truncus arteriosus), and viral/fungal infections (T-cell deficiency).
  • Chronic Granulomatous Disease (CGD): NADPH oxidase defect. Inability to produce reactive oxygen species. Susceptible to catalase-positive organisms (e.g., Staphylococcus aureus, Aspergillus, Nocardia).
Hypersensitivity Reactions
  • Type I: IgE-mediated (anaphylaxis, asthma). Immediate mast cell degranulation.
  • Type II: Cytotoxic, IgG/IgM-mediated (e.g., Hemolytic disease of the newborn, Rheumatic fever).
  • Type III: Immune complex deposition (e.g., SLE, Poststreptococcal glomerulonephritis, Serum sickness).
  • Type IV: Delayed, T-cell-mediated (e.g., PPD skin test, contact dermatitis, Graft-Versus-Host Disease).

Page 40-71: Chapter 3: Microbiology

CNS Infections and Pneumonia Profiles
  • CSF Analysis:
    • Bacterial: High PMNs, low glucose (<40 mg/dL<40\,mg/dL), high protein.
    • Viral: High lymphocytes, normal glucose, moderate protein.
    • Fungal/TB: High lymphocytes, low glucose.
  • Neisseria meningitidis: Gram-negative diplococci. Common in college dorms; associated with petechial rash and Waterhouse-Friderichsen syndrome (adrenal hemorrhage).
  • Pneumonia Etiologies:
    • Community-Acquired (CAP): Streptococcus pneumoniae (rusty sputum).
    • Hospital-Acquired (HAP): Pseudomonas aeruginosa (motile, oxidase-positive) or MRSA.
    • HIV-Associated: Pneumocystis jirovecii (PJP) at CD4 count <200 cells/mm3<200\,cells/mm^3; disc-shaped yeast on silver stain.

Page 73-85: Chapter 4: Pathology

Cellular Adaptation and Death
  • Hyperplasia: Increase in cell number.
  • Hypertrophy: Increase in cell size.
  • Atrophy: Decrease in cell size/activity.
  • Metaplasia: Change in cell phenotype (e.g., squamous to columnar).
  • Necrosis Types:
    • Coagulative: Classic for localized ischemia (infarct) in all organs except the brain.
    • Liquefactive: Classic for brain infarcts and bacterial abscesses.
    • Caseous: "Cheese-like" appearance in Tuberculosis.
Neoplasia and Markers
  • Tumor Suppressor Genes: MEN1 (menin). Syndrome of the 3 Ps: Pituitary, Parathyroid, and Pancreatic neuroendocrine tumors.
  • Amyloidosis: Extracellular deposition of misfolded β\beta-pleated sheets. Congo red stain shows apple-green birefringence under polarized light.

Page 87-102: Chapter 5: Pharmacology

Pharmacokinetics Formulas
  • Volume of Distribution (VdV_d): amount of drugplasma concentration\frac{\text{amount of drug}}{\text{plasma concentration}}
  • Half-Life (t1/2t_{1/2}): 0.7×VdCL\frac{0.7 \times V_d}{CL}
  • Loading Dose (LD): Cp×VdF\frac{C_p \times V_d}{F}
  • Maintenance Dose (MD): Cp×CL×τF\frac{C_p \times CL \times \tau}{F}
Drug Side Effects
  • ACE Inhibitors: Dry cough due to increased bradykinin.
  • Statins: Myopathy and rhabdomyolysis (↑CK\uparrow CK).
  • Isoniazid (INH): Hepatitis and B6\text{B}_6 deficiency (sideroblastic anemia/neuropathy).
  • Clozapine: Risk of agranulocytosis (monitor Absolute Neutrophil Count).

Page 104-125: Chapter 6: Public Health Sciences

Study Design and Statistics
  • Case-Control: Retrospective. Compares cases (diseased) and controls (nondiseased) for exposure frequency (Odds Ratio\text{Odds Ratio}).
  • Cohort Study: Compares exposed and non-exposed groups for disease incidence (Relative Risk\text{Relative Risk}).
  • Validity Equations:
    • Sensitivity: TPTP+FN\frac{TP}{TP + FN}
    • Specificity: TNTN+FP\frac{TN}{TN + FP}
    • Positive Predictive Value (PPV): TPTP+FP\frac{TP}{TP + FP}
    • Number Needed to Treat (NNT): 1Absolute Risk Reduction\frac{1}{\text{Absolute Risk Reduction}}

Page 127-160: Chapter 7: Cardiovascular

Ischemic Heart Disease
  • Stable Angina: Chest pain on exertion relieved by rest. Plaque >70%>70\%.
  • ST-Elevation Myocardial Infarction (STEMI): Transmural ischemia. ST elevations in contiguous leads. Immediate percutaneous coronary intervention (PCI) required.
Valvular Murmurs
  • Aortic Stenosis: Systolic crescendo-decrescendo murmur at the right upper sternal border radiating to carotids. Triad: Syncope, Angina, Dyspnea (SAD).
  • Mitral Regurgitation: Holosystolic blowing murmur at the apex radiating to the axilla.
  • Aortic Regurgitation: Early diastolic decrescendo murmur. Wide pulse pressure and bounding pulses.

Page 161-192: Chapter 8: Endocrinology

Adrenal and Thyroid Pathology
  • Cushing Disease: ACTH-secreting pituitary adenoma. Suppresses with high-dose dexamethasone.
  • Addison Disease (Primary Adrenal Insufficiency): Low cortisol/aldosterone, high ACTH. Findings: skin hyperpigmentation, hyperkalemia.
  • Graves' Disease: Primary hyperthyroidism. TSH-receptor antibodies. Signs: Exophthalmos, pretibial myxedema, goiter with bruit.
  • Diabetes Mellitus: Diagnosis requiring fasting glucose ≥126 mg/dL\ge 126\,mg/dL or HbA1c≥6.5%\text{HbA}_{1c} \ge 6.5\%.

Page 228-245: Chapter 10: Hematology and Oncology

Anemic States
  • Iron Deficiency: Microcytic (↓MCV\downarrow MCV), ↓\downarrow ferritin, ↑\uparrow TIBC.
  • Sickle Cell Disease: Hemoglobin S mutation (Glutamic acid →\rightarrow Valine). Vaso-occlusive crises, acute chest syndrome.
  • G6PD Deficiency: Bite cells and Heinz bodies after oxidative stress (e.g., fava beans, sulfa drugs).

Page 297-338: Chapter 12: Neurology

Stroke and Movement Disorders
  • Stroke: MCA artery stroke results in contralateral face/arm weakness and aphasia (if dominant hemisphere).
  • Parkinson’s Disease: Loss of dopaminergic neurons in substantia nigra. Cardinal signs: Resting tremor, rigidity, bradykinesia, postural instability.
  • Multiple Sclerosis: Autoimmune CNS demyelination. Optic neuritis, Lhermitte’s sign. Oligoclonal bands in CSF.

Page 364-394: Chapter 14: Renal

Acute Kidney Injury (AKI)
  • Prerenal: Decreased perfusion. BUN:Cr ratio>20:1\text{BUN:Cr ratio} > 20:1, FeNa<1%\text{FeNa} < 1\%.
  • Intrarenal (ATN): Tubular damage. Muddy brown granular casts. FeNa>2%\text{FeNa} > 2\%.
  • Nephrotic vs. Nephritic:
    • Nephrotic: Proteinuria (>3.5 g/day>3.5\,g/day), edema, hypoalbuminemia.
    • Nephritic: Hematuria (RBC casts), mild proteinuria, hypertension.

Page 436-465: Chapter 16: Respiratory

Pulmonary Pathologies
  • Asthma: Reversible obstructive disease. Charcot-Leyden crystals in sputum.
  • Obstructive Sleep Apnea (OSA): Excessive daytime sleepiness, snoring. Diagnosis via polysomnography (AHI>5\text{AHI} > 5).
  • Pulmonary Embolism (PE): Acute chest pain/dyspnea. S1Q3T3 pattern on ECG. CT angiography is gold standard diagnostic test.